drugset / Trial / NCT00003192
Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus
NaSingle-groupOpen-labelTreatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of aminocamptothecin in treating patients with locally advanced, metastatic, or recurrent cancer of the stomach or esophagus.
Timeline
- Start
- 1998-03
- Primary completion
- 2002-02
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 9-aminocamptothecin | Small molecule | 25 ug/m2 | Intravenous |